POTENT ANTITUMOR EFFICACY OF EX VIVO EXPANDED AND CRYOPRESERVED HUMAN NATURAL KILLER CELLS AGAINST ORTHOTOPIC PANCREATIC CANCER

被引：0
|
作者：
Park, G. [1 ]
Yang, B. [1 ]
Kim, E. [1 ]
Kim, H. [1 ]
Kim, Y. [1 ]
Cho, S. [1 ]
Hwang, Y. [1 ]
Min, B. [1 ]
机构：
[1] GCLabcell, Yongin, Gyeonggi Do, South Korea
来源：
CYTOTHERAPY | 2019年 / 21卷 / 05期
关键词：
D O I：
10.1016/j.jcyt.2019.03.361
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
91
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [31] Ex vivo purification and characterization of human invariant natural killer T cells
    Sharma, Ashish Arunkumar
    Chew, Leon
    Ladd, Mihoko
    Jen, Roger
    Lavoie, Pascal M.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2011, 373 (1-2) : 1 - 7
  • [32] Ex vivo expanded human Vγ9Vδ2+γδ-T cells mediate innate antitumor activity against human prostate cancer cells in vitro
    Liu, ZY
    Guo, BL
    Gehrs, BC
    Nan, L
    Lopez, RD
    JOURNAL OF UROLOGY, 2005, 173 (05): : 1552 - 1556
  • [33] Ex vivo expanded telomerase-specific T cells are effective in an orthotopic mouse model for pancreatic adenocarcinoma
    Hassanin, H.
    Serba, S.
    Schmidt, J.
    Maerten, A.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 158 (01): : 125 - 132
  • [34] Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma
    Kim, Hwan Mook
    Lim, Jaeseung
    Yoon, Yeo Dae
    Ahn, Ji Mi
    Kang, Jong Soon
    Lee, Kiho
    Park, Song-Kyu
    Jeong, Yu Jin
    Kim, Jin Mi
    Han, Gyoonhee
    Yang, Kyu-Hwan
    Kim, Yeon Jin
    Kim, Youngsoo
    Han, Sang-Bae
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (13) : 1793 - 1801
  • [35] Carfilzomib combined with ex vivo-expanded patient autologous natural killer cells for myeloma immunotherapy
    Chang, S. K.
    Hou, J.
    Chen, G. G.
    Yu, D. D.
    Wu, H. Q.
    Xie, Y. S.
    Hu, L. N.
    Gao, L.
    Xiao, W. Q.
    Kong, Y. Y.
    Tao, Y.
    Shi, J. M.
    NEOPLASMA, 2018, 65 (05) : 720 - 729
  • [36] An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells
    Lieberman, Nicole A. P.
    DeGolier, Kole
    Haberthur, Kristen
    Chinn, Harrison
    Moyes, Kara W.
    Bouchlaka, Myriam N.
    Walker, Kirsti L.
    Capitini, Christian M.
    crane, Courtney A.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [37] NICOTINAMIDE REJUVENATES EX-VIVO EXPANDED NATURAL KILLER CELLS AND ENHANCES THEIR TUMOR KILLING CAPACITY
    Pato, Aviad
    Hailu, Astar
    Brickman, Nurit
    Yackoubov, Dima
    Cichocki, Frank
    Peled, Amnon
    Simantov, Ronit
    Lodie, Tracey
    Rifman, Julia
    Geffen, Yona
    Berhani-Zipori, Orit
    Edri, Avishay
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A172 - A172
  • [38] Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer
    Chung, Moon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (09) : 939 - 946
  • [39] Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer
    Moon Jae Chung
    Jeong Youp Park
    Seungmin Bang
    Seung Woo Park
    Si Young Song
    Cancer Immunology, Immunotherapy, 2014, 63 : 939 - 946
  • [40] Natural Killer Cells Induce Potent Therapeutic Efficacy in Pancreatic Cancer Model via Efficient Tumor Homing and Cytolysis
    Ahn, Hyo Min
    Oh, Eonju
    Min, Bokyung
    Li, Yan
    Lian, Chun Ying
    Hong, Jin Woo
    Park, Gyeong-min
    Yang, Bitna
    Cho, Sung Yoo
    Hwang, Yu Kyeong
    Yun, Chae-Ok
    MOLECULAR THERAPY, 2020, 28 (04) : 156 - 156
12345